A study to evaluate how the intake of the test beverage and the watching of a video while taking it impacts psychology and cognitive functioning. - A study to evaluate how the intake of the test beverage and the watching of a video while taking it impacts psychology and cognitive functioning.

HUMA R&D CORP0 个研究点目标入组 120 人2023年10月20日

适应症Healthy subjects

概览

阶段: 未知
干预措施: 未指定
疾病 / 适应症: Healthy subjects
发起方: HUMA R&D CORP
入组人数: 120
状态: 已完成
最后更新: 2年前

概览研究者入排标准结局指标相似试验

概览

简要总结

暂无简介。

注册库

who.int

开始日期

2023年10月20日

结束日期

2023年12月1日

最后更新

2年前

研究类型

Interventional

性别

All

研究者

发起方

HUMA R&D CORP

入排标准

入选标准

未提供

排除标准

•1\.Subjects receiving medication or outpatient treatment for a serious disease. 2\.Subjects receiving exercise or diet therapy under the supervision of a physician. 3\.Subjects who are currently seeing a doctor for the treatment of a psychiatric disorder (e.g., depression) and/or sleep disorder or have previous history of a psychiatric disorder. 4\.Subjects with a history or current illnesses of serious diseases such as heart, liver, kidneys, digestive organs, brain, malignant tumors, immune diseases, diabetes, etc. 5\.Subjects who feel they are susceptible to motion sickness or visually induced motion sickness. 6\.Heavy drinker. 7\.Subjects who have difficulty quitting drinking from the day before the test date. 8\.Subjects who have extremely irregular eating habits, those who have an extremely irregular rhythm of life, such a those who work in shifts or late at night. 9\.Subjects who are participating in other clinical trials at the time of obtaining consent, and who plan to participate in other clinical trials within 4 weeks from the end of the study to the start of the main study of the study, or after consenting to participate in the study. 10\.Subjects who have moved residences, changed jobs, separated from close relatives, or had equivalent events within the last 3 months and thus are likely to be under a great deal of stress, or who may have such an event during the study period. 11\.Subjects with severe PMS (premenstrual syndrome) symptoms. 12\.Females who are currently pregnant or breastfeeding, or may become pregnant or start breastfeeding during the study period. 13\.Subjects with perennial allergic rhinitis. 14\.Subjects who may develop allergies related to the study. 15\.Subjects with current or previous history of drug dependence or alcohol dependence. 16\.Subjects who unable to comply during the study period.